Libra Infusions (DHA:LIBRAINFU) EPS (Diluted): BDT (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:LIBRAINFU Libra Infusions Ltd DHA:LIBRAINFU
21 GF Score
Price BDT639.50
View Full Analysis

What is Libra Infusions EPS (Diluted)?

Libra Infusions DHA:LIBRAINFU -0.25% 21 EPS (Diluted) is BDT as of . 20. GuruFocus rates DHA:LIBRAINFU with a GF Score™ of 21/100.

Libra Infusions's Earnings per Share (Diluted) for the six months ended in . 20 was BDT0.00.

Libra Infusions's EPS (Basic) for the six months ended in . 20 was BDT0.00.

Libra Infusions's EPS without NRI for the six months ended in . 20 was BDT0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Libra Infusions  (DHA:LIBRAINFU) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Libra Infusions EPS (Diluted) Related Terms

Libra Infusions EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for Libra Infusions's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Libra Infusions EPS (Diluted) Chart

Libra Infusions Annual Data
Trend
EPS (Diluted)

Libra Infusions Semi-Annual Data
EPS (Diluted)

DHA:LIBRAINFU vs SECI, LENSF, ASNB: EPS (Diluted) Comparison

For the Medical Instruments & Supplies subindustry, Libra Infusions's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Libra Infusions PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Libra Infusions's PE Ratio distribution charts can be found below:

* The bar in red indicates where Libra Infusions's PE Ratio falls into.


DHA:LIBRAINFU
21GF Score
Libra Infusions Ltd DHA:LIBRAINFU
EPS (Diluted) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Libra Infusions EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Libra Infusions's Diluted EPS for the fiscal year that ended in . 20 is calculated as

Diluted EPS (A: . 20 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-)/0
=

Libra Infusions's Diluted EPS for the quarter that ended in . 20 is calculated as

Diluted EPS (Q: . 20 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-)/0
=

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of BDT mean?
Libra Infusions (DHA:LIBRAINFU) has a EPS (Diluted) of BDT as of . 20. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Libra Infusions and its competitors.
Is Libra Infusions' EPS (Diluted) too high?
Libra Infusions' current EPS (Diluted) is BDT. Overall, Libra Infusions has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Libra Infusions' EPS (Diluted) compare to SECI and LENSF?
Libra Infusions' EPS (Diluted) of BDT can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Medical Devices & Instruments company?
A good EPS (Diluted) depends on the Medical Devices & Instruments industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Libra Infusions and its competitors. Libra Infusions's current EPS (Diluted) is BDT. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Libra Infusions stock overvalued right now?
Libra Infusions (DHA:LIBRAINFU) has a current EPS (Diluted) of BDT. The current EPS (Diluted) is BDT. Libra Infusions' overall GF Score™ is 21/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Libra Infusions (DHA:LIBRAINFU), the current EPS (Diluted) is BDT as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Libra Infusions Business Description

Address I/7, Mirpur Industrial Estate, Rupnagar, Section-2, Dhaka, BGD, 1216
Libra Infusions Ltd is engaged in manufacturing intravenous fluids. It provides products which are used for medical purposes involving surgical operations, loss of blood, weakness, and general hospitalization.
21GF Score

Get the complete analysis for DHA:LIBRAINFU

EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT639.50
Price